Try our Advanced Search for more refined results

Deals Rumor Mill: Allergan, Electrolux, Axalta

By Benjamin Horney (August 14, 2014, 6:25 PM EDT) -- The U.S. Securities and Exchange Commission is investigating whether a hostile takeover bid for Allergan Inc. — made by Valeant Pharmaceuticals International Inc. and billionaire activist investor William Ackman — constitutes a violation of securities laws, people familiar with the matter told Dow Jones on Thursday. The bid, which was launched in April with an original price tag of $48 billion and was eventually upped to about $53 billion, prompted Allergan to allege insider trading in a suit lodged earlier this month. The SEC is looking into the insider trading allegations and is still at a "relatively early stage," according to the Dow Jones report....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!